Neuner Joan M, Gilligan Mary Ann, Sparapani Rodney, Laud Purushottam W, Haggstrom David, Nattinger Ann B
Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.
Cancer. 2004 Sep 15;101(6):1323-9. doi: 10.1002/cncr.20490.
Physician volume of at least 15-30 annual breast cancer operations has been associated with higher 5-year survival rates. The authors sought to determine whether surgical volumes for breast cancer in the United States frequently reach this threshold.
The authors conducted a retrospective cohort study of 987 surgeons who operated on 8105 Medicare patients with breast cancer during 1994-1995 in 6 areas in the Surveillance, Epidemiology and End Results tumor registry. The 2-year physician volume of breast cancer operations was estimated among Medicare patients (approximating the on-average annual volumes for patients of all ages) and its association was examined with physician characteristics and with 3 measures of surgical care.
The median 2-year Medicare volume for breast cancer surgeons was 6, and 79% of physicians performed < or = 12 operations. Approximately 50% of patients were cared for by physicians who performed < or = 12 operations over 2 years, and 10% of patients were cared for by physicians who performed > or = 30 operations. Surgeon characteristics of age, female gender, general surgery board certification, and academic affiliation were associated with modestly higher volumes of breast cancer surgery. Higher surgeon volumes were associated with higher patient receipt of breast-conserving surgery, testing for hormone receptors, and lymph node dissection during mastectomy.
Most physicians who perform breast cancer surgery perform few annual operations in Medicare patients, and lower volumes are associated with differences in surgical processes of care. Because patients in the Medicare age group comprise almost 50% of all incident breast cancer cases, surgical volumes for patients of all ages also are likely to be low. It is likely that only approximately 10% of patients in the United States are treated by surgeons who performing at least 30 annual operations.
医生每年至少进行15 - 30例乳腺癌手术与较高的5年生存率相关。作者试图确定美国乳腺癌手术量是否经常达到这一门槛。
作者对1994 - 1995年在监测、流行病学和最终结果肿瘤登记处的6个地区为8105例患有乳腺癌的医疗保险患者进行手术的987名外科医生进行了一项回顾性队列研究。估计了医疗保险患者中医生的2年乳腺癌手术量(近似所有年龄段患者的平均年手术量),并研究了其与医生特征以及三种手术护理指标之间的关联。
乳腺癌外科医生的2年医疗保险手术量中位数为6例,79%的医生进行了≤12例手术。约50%的患者由在2年内进行≤12例手术的医生护理,10%的患者由进行≥30例手术的医生护理。年龄、女性性别、普通外科委员会认证和学术背景等医生特征与略高的乳腺癌手术量相关。医生手术量越高,患者接受保乳手术、激素受体检测以及乳房切除术时进行淋巴结清扫的比例越高。
大多数进行乳腺癌手术的医生每年为医疗保险患者进行手术的数量较少,手术量较低与护理手术过程的差异相关。由于医疗保险年龄组的患者几乎占所有新诊断乳腺癌病例的50%,所有年龄段患者的手术量可能也较低。在美国,可能只有约10%的患者由每年至少进行30例手术的外科医生治疗。